SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
filed pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported):November 16, 2000
UNITEDHEALTH GROUP INCORPORATED
(Exact name of registrant as specified in its charter)
| Minnesota | 0-10864 | 41-1321939 | ||
| (State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) | ||
| UnitedHealth Group Center, 9900 Bren Road East, Minneapolis, Minnesota 55343 (Address of principal executive offices) (Zip Code) | ||||
| Registrant's telephone number, including area code(612) 936-1300 | ||||
| N/A (Former name or former address, if changed since last report.) | ||||
Page 1 of 4 Pages
Exhibit Index on Page 4
On November 13, 2000, UnitedHealth Group Incorporated (the "Company") agreed to sell $400,000,000 principal amount of its 7.50% Notes due November 15, 2005 (the "Notes"), pursuant to an Underwriting Agreement and applicable Pricing Agreement each dated November 13, 2000, among the Company and Goldman, Sachs & Co. and Merrill Lynch & Co., Merrill Lynch, Pierce, Fenner & Smith Incorporated, as Representatives of the several Underwriters listed in Schedule I to the Pricing Agreement. The Notes will be issued pursuant to that certain senior debt securities Indenture dated as of November 15, 1998, as amended by an Amendment to Indenture dated as of November 6, 2000, between the Company and The Bank of New York, as Trustee (the "Indenture"), and an Officers' Certificate and Company Order dated November 16, 2000, pursuant to Sections 201, 301 and 303 of the Indenture. The Notes have been registered under the Securities Act of 1933, as amended, by a registration statement on Form S-3, File No. 333-66013.
Item 7. Financial Statements and Exhibits.
| 1.1 | Underwriting Agreement and applicable Pricing Agreement each dated November 13, 2000, among the Company and Goldman, Sachs & Co. and Merrill Lynch & Co., Merrill Lynch, Pierce, Fenner & Smith Incorporated, as representatives of the several Underwriters. | |
| 4.1 | | Officers' Certificate and Company Order dated November 16, 2000, pursuant to Sections 201, 301 and 303 of the senior debt securities Indenture dated as of November 15, 1998, between the Company and The Bank of New York, as Trustee (excluding exhibits thereto). |
| 4.2 | | Amendment to Indenture dated as of November 6, 2000, between the Company and The Bank of New York, as Trustee. |
| 4.3 | | Specimen Note. |
| | | |
2
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| UNITEDHEALTH GROUP INCORPORATED | |||
| Date: November 16, 2000 | By: | | /s/ DAVID J. LUBBEN |
David J. Lubben General Counsel & Secretary | |||
3
| (c) | Exhibits | | ||
|---|---|---|---|---|
| | | |||
| | | | | |
| 1.1 | Underwriting Agreement and applicable Pricing Agreement each dated November 13, 2000, among the Company and Goldman, Sachs & Co. and Merrill Lynch & Co., Merrill Lynch, Pierce, Fenner & Smith Incorporated, as Representatives of the several Underwriters. | |||
| | | 4.1 | | Officers' Certificate and Company Order dated November 16, 2000, pursuant to Sections 201, 301 and 303 of the senior debt securities Indenture dated as of November 15, 1998, between the Company and The Bank of New York, as Trustee (excluding exhibits thereto). |
| | | 4.2 | | Amendment to Indenture dated as of November 6, 2000, between the Company and The Bank of New York, as Trustee. |
| | | 4.3 | | Specimen Note. |
4
